TERACHEM 2018 Keynote and Invited Speakers include:

 Paul Donnelly (University of Melbourne), who is an expert in transition metal coordination chemistry, will give a lecture titled,  "The Design and Synthesis of Metal-based Radio-pharmaceuticals: The Potential for Diagnosis and Therapy with Copper, Zirconium and Rhenium Complexes."

Paul Donnelly (University of Melbourne), who is an expert in transition metal coordination chemistry, will give a lecture titled, "The Design and Synthesis of Metal-based Radio-pharmaceuticals: The Potential for Diagnosis and Therapy with Copper, Zirconium and Rhenium Complexes."

 Jonathan Engle (University of Wisconsin) has extensive experience with medical isotope production and has agreed to give a lecture on,  "Low Energy Protons for Low Energy, Therapeutic Electrons."

Jonathan Engle (University of Wisconsin) has extensive experience with medical isotope production and has agreed to give a lecture on, "Low Energy Protons for Low Energy, Therapeutic Electrons."

 Alfred Morgenstern (European Commission, Joint Research Centre, Institute for Transuranium Elements in Karlsruhe), who is an expert in alpha emitters, will present on  "Targeted Alpha Therapy with Actinium-225 and Bismuth-213."

Alfred Morgenstern (European Commission, Joint Research Centre, Institute for Transuranium Elements in Karlsruhe), who is an expert in alpha emitters, will present on "Targeted Alpha Therapy with Actinium-225 and Bismuth-213."

 Marion De Jong (Erasmus University), an expert in radiopharmaceutical development and translational research, has agreed to give a joint key lecture with Thea Maina-Nock on  “Theranostic Radiopeptides in Cancer: From bench to bed (part 1)  and  From bed back to bench (part 2).”

Marion De Jong (Erasmus University), an expert in radiopharmaceutical development and translational research, has agreed to give a joint key lecture with Thea Maina-Nock on “Theranostic Radiopeptides in Cancer: From bench to bed (part 1) and From bed back to bench (part 2).”

 Thea Maina-Nock (Demokritos), an expert in radiopharmaceutical development and translational research, has agreed to give a joint key lecture with Marion De Jong on  “Theranostic Radiopeptides in Cancer: From bench to bed (part 1)  and  From bed back to bench (part 2).”

Thea Maina-Nock (Demokritos), an expert in radiopharmaceutical development and translational research, has agreed to give a joint key lecture with Marion De Jong on “Theranostic Radiopeptides in Cancer: From bench to bed (part 1) and From bed back to bench (part 2).”

 Nik Schaefer (University Hospital Lausanne) is a trained oncologist and nuclear physician who will give a lecture on  "The Clinical Implementation of Radiometal-based Radiopharmaceuticals and the Current/Future Challenges."

Nik Schaefer (University Hospital Lausanne) is a trained oncologist and nuclear physician who will give a lecture on "The Clinical Implementation of Radiometal-based Radiopharmaceuticals and the Current/Future Challenges."